UCL Business PLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:UCL Business PLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10909
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
UCL Business PLC (UCLB), a subsidiary of University College London is a technology transfer company that supports and markets research and innovations. The company offers licensing technologies and innovations, creates shared risk joint venture businesses, and promotes and supports the transfer into industry of expertise and knowledge over a wide range of disciplines. It provides commercial expertise, legal advice, and administrative support. UCLB operates in creating spinout businesses in new industries. The company offers services such as contractual advice and formalization, business plan development, and others. It also provide technology licensing, contract negotiation and project management services. The company serves biopharma, engineering and physical sciences companies. UCLB is headquartered in London, the UK.

UCL Business PLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UCL Business PLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
UCL Business PLC, Medical Devices Deals, 2012 to YTD 2018 9
UCL Business PLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
UCL Business PLC, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Orchard Therapeutics Raises USD31 Million in Series A Venture Financing 12
Puridify Raises USD3.4 Million in Series A Financing 13
Autifony Therapeutics Raises USD12.3 Million in Extended Series A Financing 14
Puridify Raises USD1.43 Million in Seed Funding 15
Canbex Therapeutics Raises US$3 Million In Venture Financing 16
Domainex Raises Funds In First Tranche Of US$2.3 Million Venture Financing Round 17
Partnerships 18
UCL Business Forms Joint Venture with Syncona 18
Cell Therapy Catapult Forms Catapult Therapy TCR with UCL Business and Imperial Innovations 19
Licensing Agreements 20
Autolus Enters into Licensing Agreement with UCL Business 20
MeiraGTx Enters into Licensing Agreement with UCL Business 21
MeiraGTx Enters into Licensing Agreement with UCL Business 22
Autolus Amends Licensing Agreement with UCL Business 23
BioKier Enters into Licensing Agreement with UCL Business 24
Oxford Pharmascience Extends Licensing Agreement With UCL Business 25
Oxford Pharmascience Enters Into Licensing Agreement With UCL Business For Drug Delivery Technology 26
University College London Business Enters Into Licensing Agreement With TAP Biosystems For RAFT Technology 27
UCL Business PLC – Key Competitors 28
UCL Business PLC – Key Employees 29
UCL Business PLC – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Joint Venture 30
Recent Developments 31
Government and Public Interest 31
Mar 28, 2018: Liverpool researchers to help transform treatment for children with arthritis and uveitis 31
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
UCL Business PLC, Pharmaceuticals & Healthcare, Key Facts 2
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UCL Business PLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UCL Business PLC, Deals By Therapy Area, 2012 to YTD 2018 8
UCL Business PLC, Medical Devices Deals, 2012 to YTD 2018 9
UCL Business PLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Orchard Therapeutics Raises USD31 Million in Series A Venture Financing 12
Puridify Raises USD3.4 Million in Series A Financing 13
Autifony Therapeutics Raises USD12.3 Million in Extended Series A Financing 14
Puridify Raises USD1.43 Million in Seed Funding 15
Canbex Therapeutics Raises US$3 Million In Venture Financing 16
Domainex Raises Funds In First Tranche Of US$2.3 Million Venture Financing Round 17
UCL Business Forms Joint Venture with Syncona 18
Cell Therapy Catapult Forms Catapult Therapy TCR with UCL Business and Imperial Innovations 19
Autolus Enters into Licensing Agreement with UCL Business 20
MeiraGTx Enters into Licensing Agreement with UCL Business 21
MeiraGTx Enters into Licensing Agreement with UCL Business 22
Autolus Amends Licensing Agreement with UCL Business 23
BioKier Enters into Licensing Agreement with UCL Business 24
Oxford Pharmascience Extends Licensing Agreement With UCL Business 25
Oxford Pharmascience Enters Into Licensing Agreement With UCL Business For Drug Delivery Technology 26
University College London Business Enters Into Licensing Agreement With TAP Biosystems For RAFT Technology 27
UCL Business PLC, Key Competitors 28
UCL Business PLC, Key Employees 29
UCL Business PLC, Subsidiaries 30
UCL Business PLC, Joint Venture 30

List of Figures
UCL Business PLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UCL Business PLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
UCL Business PLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[UCL Business PLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EDP Renovaveis, S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' EDP Renovaveis, S.A. Mergers an …
  • Centric Health Corp (CHH):企業の財務・戦略的SWOT分析
    Summary Centric Health Corp (CHC) is a healthcare and wellness service provider. The company operates through specialty pharmacy, orthotics, and surgical and medical centres. Its pharmacies provide traditional pharmacy services such as compounding and dispensing medications, and clinical and special …
  • BARMER GEK:企業の戦略的SWOT分析
    BARMER GEK - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • University of Aberdeen:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Aberdeen (UOA) is an educational and research institution that offers educational and research programs. The university offers undergraduate, graduate, postgraduate and research programs. It provides undergraduate and postgraduate courses in the areas of education, creative art …
  • Nippon Carbide Industries Co., Inc. (4064):企業財務及び戦略的SWOT分析
    Summary Nippon Carbide Industries Co., Inc. (Nippon) is a chemical company that manufactures and markets chemicals, plastics and resins, plastics films and electronic materials. The company offers products such as specialty polymers, calcium carbide, hydrazine hydrate, cyanamide solution, alkyl mono …
  • Olam International Limited:企業の戦略・SWOT・財務分析
    SummaryOlam International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Canon U.S.A., Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Canon U.S.A., Inc. (Canon), a subsidiary of Canon Inc. is a technology company that designs, develops and commercializes imaging equipment and information systems, and digital imaging solutions. The company offers products such as cameras and camcorders, lenses, flashes and binoculars, offic …
  • Denki Kagaku Kogyo Kabushiki Kaisha:企業の戦略・SWOT・財務分析
    SummaryDenki Kagaku Kogyo Kabushiki Kaisha - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • Mindax Limited:企業の戦略・SWOT・財務情報
    Mindax Limited - Strategy, SWOT and Corporate Finance Report Summary Mindax Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Wild Stream Exploration, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Wild Stream Exploration, Inc. M …
  • NTT DATA, Inc. (formerly Keane, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NTT DATA, Inc. (formerly Keane, …
  • Pyramisa Hotels and Resorts:企業の戦略・SWOT・財務分析
    SummaryPyramisa Hotels and Resorts - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Qwest Communications International, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Qwest Communications Internatio …
  • Memry Corporation:企業の戦略的SWOT分析
    Memry Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • KB Insurance Co., Ltd. (002550):企業財務及び戦略的SWOT分析
    Summary KB Insurance Co., Ltd. (KB Insurance) is a financial service provider that offers non-life insurance products and services to individuals and corporate. The company offers coverage for various risks including fire, liability, package, title, guarantee, auto, bicycle, maritime, injury, techno …
  • Bharat Forge Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Bharat Forge Limited Mergers an …
  • Tokyo Electron Limited:企業の戦略・SWOT・財務分析
    Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report Summary Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Reservoir Capital Corp (REO):企業の財務及び戦略的SWOT分析
    Summary Reservoir Capital Corp (Reservoir Capital) is a renewable energy company that develops renewable energy projects. The company energy projects include Brodavero 1, Brodavero 2, and Vranjska Banja in Southern Serbia and Vojvodina Province in Northern Serbia. Reservoir Capital has hydroelectric …
  • SCANA Corporation (SCG):企業のM&A・提携動向(エネルギー分野)
    Summary SCANA Corporation (SCANA) is an electric utility. The company generates, transmits, distributes and sells electricity and natural gas. SCANA offers fiber optic and other telecommunications services through its non regulated subsidiaries. The company provides various services in terms of cont …
  • Genel Energy Plc (GENL):石油・ガス:M&Aディール及び事業提携情報
    Summary Genel Energy Plc (Genel) is an independent upstream oil and gas company. It carries out acquisition, exploration, and production operations. It has interest in Taq Taq and Tawke in the Kurdistan region. The company develops the Miran and Bina Bawi gas fields in Zagros Fold belt in the Kurdis …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆